InvestorsHub Logo
Followers 97
Posts 128742
Boards Moderated 1
Alias Born 07/24/2016

Re: None

Thursday, 03/02/2017 9:11:01 AM

Thursday, March 02, 2017 9:11:01 AM

Post# of 2875
$RGBP premarket news out! Regen BioPharma, Inc. Licenses NR2F6 Technology for Cancer Treatment and Autoimmune Disorders to CheckPoint Immunology Inc.
http://finance.yahoo.com/news/regen-biopharma-inc-licenses-nr2f6-130000603.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.